亚太药业：聘任邱中勋为公司总经理

Core Viewpoint - The control of Zhejiang Apac Pharmaceutical Co., Ltd. has changed, leading to significant management resignations and new appointments [1] Group 1: Management Changes - The board of directors received written resignation reports from Mr. Cen Jianwei (General Manager), Mr. Xu Wei (Board Secretary), and Mr. Xu Jingyang (Chief Financial Officer) [1] - The resignations are effective immediately upon delivery to the board, and the individuals will no longer hold any positions within the company [1] - Mr. Qiu Zhongxun has been appointed as the new General Manager, Mr. Zong Hao as the new Board Secretary, and Mr. Chen Xiaobiao as the new Chief Financial Officer [1] Group 2: Context of Changes - The management changes are a result of the company's control shift as per the Share Transfer Agreement and related arrangements [1] - The article highlights a trend of young executives, including a 26-year-old who recently returned from studying at a prestigious U.S. university, taking on significant roles in A-share companies [1]